期刊文献+

同位素稀释质谱法在蛋白质计量比对中的应用 被引量:2

Application of Isotope Dilution Mass Spectrometry in Quantitative Comparison of Protein Detection Ability
下载PDF
导出
摘要 在医疗卫生领域,蛋白质作为生物标志物是疾病预测、诊断和治疗的检测指标,是体外诊断结果的重要依据。常用的检测方法有酶联免疫吸附法、免疫荧光法、胶体金法等,但是这些方法不具有溯源性,导致检测结果没有可比性。目前,同位素稀释质谱法是一种被国际计量委员会认可,用于蛋白质含量测定的具有溯源性的方法。参加“同位素稀释质谱法在蛋白质测量能力计量比对”任务,能够考察实验室的人员检测水平,从而发现现存的弊端,并进行改善,进而提升参与者的专业水平。 In the field of medical and health,protein as biomarker is the detection index of disease prediction,diagnosis and treatment,and is an important basis for in vitro diagnosis.The commonly used detection methods include enzyme-linked immunosorbent assay,immunofluorescence assay,colloidal gold assay,etc.,but these methods are not traceable,leading to no comparison of detection results.At present,isotope dilution mass spectrometry is a traceable method approved by the International Committee of Weights and Measures for the determination of protein content.Participating in the task of"Measurement and Comparison of Protein Measurement Ability by Isotope Dilution Mass Spectrometry"can inspect the testing level of laboratory personnel,so as to find existing drawbacks and improve them,thus enhancing the professional level of participants.
作者 朱文 倪鑫茹 徐昇 ZHU Wen;NI Xinru;XU Sheng
出处 《计量与测试技术》 2022年第7期12-14,共3页 Metrology & Measurement Technique
关键词 同位素稀释质谱法 蛋白质检测 计量比对 isotope dilution mass spectrometry protein detection quantitative comparison
  • 相关文献

参考文献3

二级参考文献19

  • 1Mantovani A, Garlanda C, Doni A, et al. Pentraxins in innate immunity: from C-reactive protein to the long pentraxin PTX3[J]. Journal of Clinical Immunology, 2008, 28(1): 1-13.
  • 2Pepys MB, Hirschfield GM. C-reactive protein: a critical update[J]. American Society for Clinical Investigation, 2003, 111(12): 1805-1812.
  • 3Rifai N, Ridker PM. High-sensitivity C-reactive protein: A novel and promising marker of coronary heart disease[J]. Clinical Chemistry, 2001, 47(3): 403-411.
  • 4Tarkkinen P, Palenius T, Lovgren T. Ultrarapid, uhrasensitive one-step kinetic immunoassay for C-reactive protein (CRP) in whole blood samples: Measurement of the entire CRP concentration range with a single sample dilution[J]. Clinical Chemistry, 2002, 48(2): 269-277.
  • 5Verma S, Yeh E T. C-reactive protein and atherothrombosis- beyond a biomarker: an actual partaker of lesion formation[J]. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2003, 285(5): R1253-R1256.
  • 6Verma S, Szmitko P E, Ridker P M. C-reactive protein comes of age[J]. Nature Clinical Practice Cardiovascular Medicine, 2005, 2(1): 29-36.
  • 7Libby P, Ridker P M, Maseri A. Inflammation and atherosclerosis[J]. Circulation, 2002, 105(9): 1135-1143.
  • 8Danesh J, Whincup P, Walker M, et al. Low grade inflammation and coronary heart disease: prospective study and updated meta- analyses[J]. British Medical Journal, 2000, 321 (7255): 199-204.
  • 9Anderson L. Candidate-based proteomics in the search for biomarkers of cardiovascular disease[J]. Journal of Physiology, 2005, 563(1): 23-60.
  • 10Armani A, Becker RC. The biology, utilization, and attenuation of C-reactive protein in cardiovascular disease: Part I[J]. American Heart Journal, 2005.149(6): 971-976.

共引文献7

同被引文献17

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部